Aquila Biolabs is a Germany-based startup founded in 2014 that specializes in providing sensors, actuators, and software for the bioprocessing industry. The company's slogan, "Sensors, Actuators and Software for Bioprocessing," encapsulates its core focus on developing innovative technological solutions for biopharma and biotechnology industries.
In November 2015, Aquila Biolabs secured a Seed Round investment from Seed Fond Aachen, KfW, and TechVision Fund, signifying early investor interest in the potential of the company's offerings.
Notably, in 2021, Aquila Biolabs was acquired by Scientific Bioprocessing, Inc. The acquisition marked a significant milestone for Aquila Biolabs, aligning it with a larger entity and potentially signaling a new phase of growth and development for its technologies.
For further information, interested parties are directed to visit www.scientificbio.com for details regarding Aquila Biolabs' acquisition and its current position within Scientific Bioprocessing, Inc.